These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6653671)

  • 1. Differential tolerance to the intestinal inhibitory effect of opiates in mice.
    Petersen DW; Fujimoto JM
    Eur J Pharmacol; 1983 Nov; 95(3-4):225-30. PubMed ID: 6653671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    Lange DG; Roerig SC; Fujimoto JM; Busse LW
    J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of tolerance to respiratory depression in morphine- and etorphine-pellet-implanted mice.
    Roerig SC; Fujimoto JM; Lange DG
    Brain Res; 1987 Jan; 400(2):278-84. PubMed ID: 3815075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.
    Peracchia F; Bianchi G; Fiocchi R; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 Oct; 36(10):699-701. PubMed ID: 6150093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential analgesic cross-tolerance to morphine between lipophilic and hydrophilic narcotic agonists.
    Paktor J; Vaught JL
    Life Sci; 1984 Jan; 34(1):13-21. PubMed ID: 6141509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence.
    Roerig SC; Fujimoto JM; Franklin RB; Lange DG
    Brain Res; 1985 Feb; 327(1-2):91-6. PubMed ID: 4039210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice.
    Rady JJ; Fujimoto JM
    J Biomed Sci; 2000; 7(3):258-69. PubMed ID: 10810246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Log dose/response curve flattening in rats after daily injection of opiates.
    Mucha RF; Kalant H
    Psychopharmacology (Berl); 1980; 71(1):51-61. PubMed ID: 6779325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unidirectional non-cross tolerance to etorphine in morphine-tolerant mice and role of the blood-brain barrier.
    Lange DG; Fujimoto JM; Fuhrman-Lane CL; Wang RI
    Toxicol Appl Pharmacol; 1980 Jun; 54(2):177-86. PubMed ID: 7423486
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross tolerance to etorphine in rats tolerant to morphine-induced antidiuresis.
    Fuhrman-Lane C; Tseng LF; Fujimoto JM
    Life Sci; 1982 Jun; 30(26):2317-23. PubMed ID: 7109848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intrinsic efficacy on opioid tolerance.
    Duttaroy A; Yoburn BC
    Anesthesiology; 1995 May; 82(5):1226-36. PubMed ID: 7741298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unequal opiate cross-tolerance to morphine in the locomotor-activation model in the mouse.
    Brase DA
    Neuropharmacology; 1986 Mar; 25(3):297-304. PubMed ID: 2871515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body temperature effects of opioids in rats: intracerebroventricular administration.
    Geller EB; Rowan CH; Adler MW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1761-5. PubMed ID: 2942949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
    Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance.
    Gabra BH; Bailey CP; Kelly E; Sanders AV; Henderson G; Smith FL; Dewey WL
    Brain Res; 2007 Jul; 1159():86-93. PubMed ID: 17582387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
    Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo opiate binding unchanged in tolerant/dependent mice.
    Dum J; Meyer G; Höllt V; Herz A
    Eur J Pharmacol; 1979 Oct; 58(4):453-60. PubMed ID: 574455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.